Antibiotice S.A. (BVB: ATB)

Romania flag Romania · Delayed Price · Currency is RON
2.560
+0.020 (0.79%)
At close: Jan 28, 2025
35.45%
Market Cap 1.72B
Revenue (ttm) 657.89M
Net Income (ttm) 92.29M
Shares Out 671.34M
EPS (ttm) 0.14
PE Ratio 18.62
Forward PE n/a
Dividend 0.08 (3.26%)
Ex-Dividend Date Sep 23, 2024
Volume 58,040
Average Volume 131,742
Open 2.540
Previous Close 2.540
Day's Range 2.520 - 2.570
52-Week Range 1.580 - 3.440
Beta 0.14
RSI 39.97
Earnings Date Feb 25, 2025

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania. The company produces medicines for a range of therapeutic areas, such as cardiovascular system, alimentary tract and metabolism, musculo-skeletal system, nervous system, antiinfectives, respiratory system, dermatological, food supplements, sensory organs, genito-urinary apparatus and sexual hormones, varia, and blood and blood forming organs, as well as veterinary medicinal products. It offers its products in the form of sterile injectable powders, capsules, tablets, ointments, ... [Read more]

Industry Pharmaceutical Preparations
Founded 1955
Employees 1,352
Stock Exchange Bucharest Stock Exchange
Ticker Symbol ATB
Full Company Profile

Financial Performance

In 2023, Antibiotice's revenue was 615.29 million, an increase of 21.84% compared to the previous year's 505.00 million. Earnings were 81.09 million, an increase of 57.54%.

Financial Statements

News

There is no news available yet.